IGI Logo

The markets are expected to open marginally higher today as trends in GIFT Nifty indicate a positive start for the broader index after Nifty closed 84 points higher at 22,096.75 on Friday.

JSW Energy:

The firm’s subsidiary has engaged in an agreement with Reliance Power for the procurement of a 45 MW wind energy project in Maharashtra, valued at Rs 132 crore.

Lupin:

The organization is set to divest its trade generics operations in India to its subsidiary for Rs 100–120 crore, transacted as a slump sale.

Sanghi Industries:

Ambuja Cements, the promoter, has divested a 2% stake in the firm for Rs 258 crore. Post-transaction, the promoter’s shareholding is at 60.44%.

UNO Minda:

The corporation has formalized a technical licence pact with Starcharge Energy for the production and commercialization of EV supply equipment within India.

Raymond:

The company’s board has sanctioned the sale of its complete stake in the wholly owned subsidiaries, Raymond Apparel and Ultrashore Realty, for a sum of Rs 1.26 crore.

Exide Industries:

The enterprise has executed an investment of Rs 110 crore in its subsidiary Chloride Metals through a rights issue.

Maruti Suzuki India:

The firm has initiated a recall for 11,185 units of the Baleno and 4,190 units of the Wagon R due to a potential defect in the fuel pump motor.

Mangalore Refinery and Petrochemicals:

The board has greenlit the purchase of 1.35 crore shares of Mangalore SEZ at Rs 47.18 crore from IL&FS, which will boost the company’s stake from 0.96% to 27.92%.

Adani Ports:

The corporation is set to acquire a 95% stake in Gopalpur Ports for an enterprise value of Rs 3,080 crore. Definitive agreements have been signed to purchase a 56% stake from SP Group and a 39% stake from Orissa Stevedores.

Bharti Airtel:

The firm has incurred a penalty of Rs 114 crore by the Gurugram Tax Authority over claims of insufficient tax payment.

ICICI Securities:

The firm was issued a warning by SEBI following a review of its documentation and records related to merchant banking operations.

Zydus Lifesciences:

The company has received tentative approval from the U.S. FDA for its Letermovir tablets.      

Please refer disclaimer at http://www.aretesecurities.com/

SEBI Regn. No.: INM000012740